Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment: Etiologic Factors, Forms and Potential Association With Chronic Comorbidities Unrelated to Immune Deficiency.

NCT02334943 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02334943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02334943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment: Etiologic Factors, Forms and Potential Association With Chronic Comorbidities Unrelated to Immune Deficiency.
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
March 31, 2015
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

activation of latent virus, hiv-related gut disease - cause unknown, immune deficiency, other diagnoses, comorbidities, and complications